Randomized Open-Label Clinical Trial Comparing Prednisolone and Cyclosporine With a Nonrandomized Active Control for...

Area of Science:

• Veterinary Medicine
• Immunology
• Gastroenterology

Background:

• Chronic pancreatitis in cats is typically managed symptomatically.
• Limited data exists on immunomodulatory treatments for feline chronic pancreatitis.

Purpose of the Study:

• To compare symptomatic treatment, prednisolone, and cyclosporine for feline chronic pancreatitis.
• Evaluate effects on serum feline pancreatic lipase immunoreactivity (fPLI) and clinical activity index (CAI).

Main Methods:

• A 3-week randomized open-label trial with 48 cats diagnosed with chronic pancreatitis.
• Cats were assigned to symptomatic treatment, prednisolone, or cyclosporine groups.
• Serum fPLI and CAI were measured at baseline, Day 10, and Day 21.

Main Results:

• Cyclosporine significantly decreased fPLI concentrations compared to control and prednisolone groups.
• Prednisolone led to a greater reduction in CAI compared to the control group.
• Cyclosporine did not show a significant improvement in CAI compared to the control group.

Conclusions:

• Cyclosporine demonstrated superior efficacy in reducing fPLI in cats with chronic pancreatitis over 3 weeks.
• Prednisolone improved clinical signs more effectively than cyclosporine or symptomatic treatment alone.
• Further research may explore combination therapies or longer treatment durations.